TEM tempus.com: Quarterly EPS earnings growth

Graphic logo of Tempus (TEM)

Tempus AI, Inc (TEM) minimizes risks by synthesizing AI and genetics for targeted therapy and pharmaceutical development. The quarterly EPS growth trajectory confirms this trend, with the indicator currently standing at 81.60. Data integration within clinics creates long-term rent, while the aggressive monetization of the largest genome library ensures the rapid scaling of the precision medicine platform.

TEM: Tempus AI Year-over-year earnings per one share growth for the last 12 months 06/15/2024 - 11/11/2026

Comprehensive metric breakdowns and analytics for Tempus AI, Inc (TEM)

- share price and expert price forecast:
Stock Price Tempus AI Inc|TEM - Analyst Consensus Forecast
- company stock capitalization data:
Market Capitalization Tempus AI Inc|TEM - Company Buyout Price
- balance sheet net asset value indicators:
Accounting Value per Share Tempus|TEM - Accounting Value of Company|Market Capitalization to Book Value Ratio tempus.com|TEM - Company Total Asset Base
- debt level and financial liquidity data:
Debt to Equity Tempus AI, Inc|TEM - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital tempus.com|TEM - Company Total Debt|Debt to Book Value Tempus AI Inc|TEM - Amount of Long-Term Liabilities|Company Short-Term Debts Tempus|Quick Liquidity tempus.com
- earnings and valuation multiples information:
TEM - Net Income|Projected Future Earnings Tempus AI, Inc|TEM - Price to Earnings Multiple|Future Price to Earnings Tempus AI, Inc.|TEM - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Tempus AI Inc|TEM - Operating profit EBITDA|Net earnings per share for the last 12 months Tempus|TEM - Earnings per share for the last four quarters|Quarterly EPS earnings growth tempus.com|TEM - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Tempus AI, Inc
Basic company analysis:Tempus AI, TEM
Manufactured product of Tempus AI, Inc

Investors assess fundamental capital risks through net earnings per share dynamics. For Tempus AI, Inc (TEM), the efficiency of diagnostic equipment upgrades and the expansion of IT capacity have become critical factors. The quarterly EPS growth trajectory reflects the percentage change of this metric between reports. An upward curve confirms the successful monetization of the technology stack, while a decline signals excessive expenditures. A positive trend minimizes the risk of sell-offs.

Competitor analysis for Tempus AI, Inc

QGEN: Quarterly EPS earnings growth|Ionis Pharmaceuticals, Inc. (IONS) - Quarterly EPS earnings growth|RGEN (Repligen Corp.) - Quarterly EPS earnings growth|Avidity Corp (RNA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CRSP (CRISPR Therapeutics AG)|WGS (genedx.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth RARE (Ultragenyx)|Year-over-year net earnings per share change for the last twelve months Beam Therapeutics Inc (BEAM)|SRPT - Year-over-year earnings per share growth for the last twelve months|TWST (Twist Bioscience Corp) - Year-over-year earnings per share growth for the last 12 months|TXG: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months intelliatx.com|Year-over-year net earnings per share growth for the last 12 months STOK|BLFS (BioLife Solutions Inc) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth WVE|MAZE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Sionna Therapeutics Inc SION|PRME - Year-over-year net earnings per share growth for the last 12 months|Taysha Gene Therapies, Inc. - Quarterly EPS earnings growth|QURE (uniQure NV) - Year-over-year earnings per share growth for the last 12 months|MeiraGTx PLC (MGTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months RGNX|SLDB (Solid Biosciences Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth ocugen.com|Year-over-year net earnings per share growth for the last 12 months PACB (PacBio)|Year-over-year earnings per share growth rate for the last twelve months BNTC|Quarterly EPS earnings growth DSGN (Design Pharma)|Rocket Corp (RCKT) - Earnings per share growth in annualized terms for the last twelve months|FDMT - Year-over-year earnings per share growth for the last twelve months|Lexeo Therapeutics (LXEO) - Year-over-year net earnings per share growth for the last 12 months|korrobio.com (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months EDIT (Editas Medicine Inc)|Year-over-year net earnings per share growth for the last 12 months SLN|Quarterly EPS earnings growth ProQR Therapeutics NV|Year-over-year earnings per share growth for the last twelve months Codexis, Inc. (CDXS)|Year-over-year net earnings per share change for the last twelve months sangamo.com|Nautilus Bio - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months MGX|Precision BioSciences - Quarterly EPS earnings growth|GBIO - Quarterly EPS earnings growth|BOLD: Quarterly EPS earnings growth|XCUR - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months IMNN|PHIO: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth MBIO|Year-over-year net earnings per share change for the last twelve months transcodetherapeutics.com|Year-over-year earnings per share growth for the last twelve months Bionano Genomics BNGO|APDN: Year-over-year earnings per share growth for the last 12 months|bluebird bio - Quarterly EPS earnings growth|ImmunoPrecise Antibodies (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|OMIC: Year-over-year earnings per share growth rate for the last twelve months|RGLS (Regulus Therapeutics) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months syros.com SYRS|Year-over-year earnings per share growth for the last twelve months Telesis Bio (TBIO)|Year-over-year net earnings per share growth for the last 12 months TRACON Pharmaceuticals Inc. TCON|Quarterly EPS earnings growth UBX (Unity Bio)